<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study investigated the prevalence of antibody against annexin II (A2) in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>It also explored the role of this antibody in <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Purified recombinant A2 was used in ELISA to measure the levels of IgG anti-A2 antibody in 101 APS patients, 41 SLE patients with <z:mp ids='MP_0005048'>thrombosis</z:mp>, 124 SLE patients without <z:mp ids='MP_0005048'>thrombosis</z:mp>, and 120 healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>The positive rates of IgG anti-A2 antibody in APS patients and SLE patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> were 21.8 and 26.8%, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Both values are significantly higher than that in SLE patients without <z:mp ids='MP_0005048'>thrombosis</z:mp> (6.5%) </plain></SENT>
<SENT sid="5" pm="."><plain>IgG anti-A2 antibody is associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> and/or pregnancy morbidity (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>The data show that the levels of anti-A2 antibody are higher in APS patients and SLE patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Further, the presence of this antibody is associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> and/or pregnancy morbidity, suggesting that anti-A2 antibody may be helpful in identifying potential APS cases </plain></SENT>
</text></document>